MTOR and cancer: The mammalian target of rapamycin (mTOR) /ribosomal protein S6 kinase (p70S6K) pathway and p38/Jun-amino-terminal kinase (JNK) pathway are proposed to be highly associated with the anti-cancerous activities of TSN in various cancer cell lines [18,20].